• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Dealing with Your Manager

Need help dealing with a difficult manager? Solicit advice from your fellow reps here.
Replies
5
Views
5K
anonymous
Replies
10
Views
8K
anonymous
Replies
5
Views
3K
anonymous
Replies
7
Views
5K
anonymous
Replies
5
Views
7K
anonymous
Replies
4
Views
3K
anonymous
Replies
0
Views
3K
JohnTeller
Replies
19
Views
23K
anonymous
Replies
220
Views
76K
anonymous
Replies
12
Views
11K
Anonymous
Replies
1
Views
5K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
6
Views
5K
Anonymous
Replies
8
Views
8K
Anonymous
Replies
4
Views
8K
Anonymous
Replies
7
Views
9K
Anonymous
Replies
23
Views
14K
Anonymous